Key result
MicroRNA expression in human adipose tissue is fat-depot specific, with 16 miRNAs showing significant expression differences between omental and subcutaneous depots, and correlates with adipocyte phenotype and metabolic parameters.
Cross-Sectional (n=15)
No
Answers are grounded in this paper and cite their sources.
miRNA expression differs between omental and subcutaneous fat depots and correlates with key metabolic parameters in obesity and type 2 diabetes.
MicroRNAs (miRNAs) are small non-coding RNAs, that play important regulatory roles in a variety of biological processes, including development, differentiation, apoptosis, and metabolism. In mammals, miRNAs have been shown to modulate adipocyte differentiation. Therefore, we performed a global miRNA gene expression assay in different fat depots of overweight and obese individuals to investigate whether miRNA expression in human adipose tissue is fat-depot specific and associated with parameters of obesity and glucose metabolism. Paired samples of abdominal subcutaneous (SC) and intraabdominal omental adipose tissue were obtained from fifteen individuals with either normal glucose tolerance (NGT, n = 9) or newly diagnosed type 2 diabetes (T2D, n = 6). Expression of 155 miRNAs was carried out using the TaqMan(R)MicroRNA Assays Human Panel Early Access Kit (Applied Biosystems, Darmstadt, Germany). We identified expression of 106 (68%) miRNAs in human omental and SC adipose tissue. There was no miRNA exclusively expressed in either fat depot, suggesting common developmental origin of both fat depots. Sixteen miRNAs (4 in NGT, 12 in T2D group) showed a significant fat depot specific expression pattern. We identified significant correlations between the expression of miRNA-17-5p, -132, -99a, -134, 181a, -145, -197 and both adipose tissue morphology and key metabolic parameters, including visceral fat area, HbA(1c), fasting plasma glucose, and circulating leptin, adiponectin, interleukin-6. In conclusion, microRNA expression differences may contribute to intrinsic differences between omental and subcutaneous adipose tissue. In addition, human adipose tissue miRNA expression correlates with adipocyte phenotype, parameters of obesity and glucose metabolism.
No takes yet. Share an insight, caveat, or question.
Klöting et al. (2009) conducted a cross-sectional in Obesity and Type 2 Diabetes (n=15). Omental adipose tissue and Type 2 Diabetes status vs. Subcutaneous adipose tissue and normal glucose tolerance was evaluated on MicroRNA expression differences between omental and subcutaneous adipose tissue, and between NGT and T2D patients. MicroRNA expression in human adipose tissue is fat-depot specific, with 16 miRNAs showing significant expression differences between omental and subcutaneous depots, and correlates with adipocyte phenotype and metabolic parameters.
Synapse has enriched 10 related papers. Consider them for comparative context: